Ryan Christopher Neal, MD
Houston,TX
Summary
Hard-working physician leader with exceptional experience leading teams, delivering results and exceeding expectations. Creative and motivated leader adept at utilizing exceptional design and planning strengths to accomplish complex projects. Skilled in teaching new concepts and best practice strategies. Accomplished leader who achieves success by directing high-producing teams while developing lasting employee rapport. Exceptional knowledge of achieving company goals, cost-reduction methods and streamlining production processes.
Overview
28
28
years of professional experience
1
1
Certificate
Work History
Division Head of Hospital Medicine
Houston Methodist Hospital
01.2019 - Current
- Implemented change management initiatives to successfully transition the division through organizational restructuring.
- Supported corporate initiatives by aligning divisional strategies with overarching organizational goals.
- Managed budgets effectively, ensuring optimal resource allocation for division projects and goals.
- Enhanced employee engagement through regular communication, feedback sessions, and recognition programs.
- Mentored junior staff, fostering professional growth and development across the division.
Chair of Diversity, Equity and Inclusion Committee
Weill Cornell Medicine
01.2022 - Current
- Championed diversity initiatives, creating a more inclusive departmental culture for all members.
- Fostered relationships with stakeholders, promoting collaboration and partnership opportunities.
- Planned and oversaw meetings in accordance with mission statement and future hospital system initiatives.
- Represented the organization at public events, advocating for its mission and values in the community.
- Developed long-term strategic plans to guide organizational growth and success.
Assistant Professor of Clinical Medicine
Weill Cornell Medical College at Houston Methodist
10.2020 - Current
- Evaluated student and resident performance through comprehensive assessments, identifying areas of improvement and providing targeted feedback for growth.
- Contributed to departmental goals by serving on various committees focused on curriculum development, assessment strategies, and accreditation requirements.
- Mentored students and communicated internship and employment opportunities.
Assistant Professor of Clinical Medicine
Houston Methodist Academic Institute
10.2020 - Current
- Maintained an up-to-date knowledge of subject matter by attending conferences, workshops, and webinars relevant to the field of study.
- Performed research to serve as basis for academic writing for publication.
Service Line Chief of Internal Medicine
Baylor St. Luke’s Medical Center
06.2017 - 12.2018
- Setting the vision and strategic goals for the Hospital Medicine Service Line at Baylor St. Luke's Medical Center.
- Leading and developing a team of physicians, nurses, and other healthcare professionals.
- Fostering a culture of excellence, collaboration, and continuous improvement within the service line.
- Self-motivated, with a strong sense of personal responsibility.
- Proven ability to learn quickly and adapt to new situations.
- Collaborating with other departments and service lines to integrate and coordinate care across the hospital.
Attending/ Staff Physician
Assistant Clinical Professor of Medicine
11.2010 - 12.2018
- Demonstrated strong clinical judgement in managing challenging cases while prioritizing patient safety at all times.
- Conducted thorough patient assessments to accurately diagnose and develop personalized treatment plans.
- Collaborated with nursing staff to ensure seamless coordination of care for each patient, leading to better overall experiences.
- Evaluated patient satisfaction data to identify areas for improvement and implemented changes accordingly, promoting continuous quality enhancement.
- Mentored junior physicians, sharing knowledge and expertise to foster their professional growth.
Member of the Medical Executive Committee
Baylor St. Luke’s Medical Center
01.2017 - 12.2018
- Participated in strategic planning, forecasting, and reporting processes to ensure accurate data-driven decision-making capabilities across the organization.
- Cultivated an environment that prioritized professional development opportunities for physicians employees at all levels within the organization.
- Championed innovative initiatives for continuous business growth, resulting in increased revenue and market share.
- Evaluated operational efficiency through regular performance reviews, identifying opportunities for improvement and implementing appropriate solutions.
- Leveraged data-driven insights to inform strategic decision-making processes and drive targeted, impactful results.
Regional Medical Director
Larkin and Stroh Associates- LSA Hospitalist
11.2014 - 12.2018
- Monitored regional performance metrics to identify trends, anticipate challenges, and drive improvements in patient care delivery.
- Promoted interdisciplinary collaboration among various departments for improved communication and coordinated care delivery.
- Streamlined administrative processes by implementing standardized procedures across all facilities within the region.
- Enabled better decision-making by regularly presenting actionable insights derived from regional performance data to senior leadership.
- Reduced employee turnover rates through effective recruitment, retention, and professional development strategies.
Co- Medical Director (Co-PGL)
Inpatient Consultants of Texas-Hospitalist
11.2010 - 10.2014
- Supervised clinical staff, providing continuous professional development opportunities and training to maintain and strengthen competencies.
- Improved patient outcomes and delivery of care through improved clinical quality processes.
- Managed multidisciplinary teams, fostering collaboration between various healthcare professionals for optimal patient care.
- Enhanced operational performance by identifying areas of improvement and implementing change management strategies.
Staff Physician
Diagnostic Clinic of Houston
01.2008 - 10.2010
- Conducted thorough patient assessments to accurately diagnose and develop personalized treatment plans.
- Enhanced patient care by implementing evidence-based practices and consistently staying updated on medical advancements.
- Collaborated with nursing staff to ensure seamless coordination of care for each patient, leading to better overall experiences.
Attending/Staff Physician
The Methodist Hospital
07.1996 - 10.2010
- Optimized patient outcomes through timely interventions, close monitoring, and effective follow-up care.
- Enhanced patient care by implementing evidence-based practices and consistently staying updated on medical advancements.
- Participated in quality improvement initiatives to enhance departmental performance metrics and maintain high standards of care.
- Conducted thorough patient assessments to accurately diagnose and develop personalized treatment plans.
- Streamlined workflow processes, resulting in more efficient use of resources within the department.
Medical Director of Cardiac Rehabilitation
The Methodist DeBakey Heart Center
07.1996 - 01.2008
- Enhanced operational performance by identifying areas of improvement and implementing change management strategies.
- Led quality improvement initiatives resulting in enhanced clinical service delivery across departments.
- Promoted a safe work environment by implementing safety protocols, reducing workplace injuries among hospital staff members.
- Improved patient care quality by implementing new clinical policies and procedures.
- Optimized case and clinical management and recommended plans to improve safety and health programs.
Faculty for the Center for Cardiovascular Disease Prevention
Baylor College of Medicine/The Methodist DeBakey Heart Center
07.2002 - 01.2008
- Supported cardiovascular research by overseeing the development and implementation of research programs focusing on cardiovascular diseases and treatments.
- Design, implement, and oversee clinical research projects and trials related to cardiovascular health.
- Ensure that all research activities comply with regulatory standards and ethical guidelines.
- Evaluate and select appropriate new technologies and methodologies for research projects.
- Led a team of researchers, clinicians, and support staff involved in cardiovascular research.
- Manage budgets and resources for research projects, ensuring efficient use of funds and equipment.
- Oversee data collection, analysis, and interpretation of research data.
- Ensure that research findings are documented and published in reputable scientific journals or presented at conferences.
Assistant Professor of Medicine
Section of General Internal Medicine
06.1996 - 06.2002
- Collaborated with fellow faculty members to develop interdisciplinary courses, promoting a comprehensive approach to medicine education.
- Contributed to learning of medical students, graduate students, interns and residents through classroom teaching and in one‐on‐one out-of-class situations.
- Mentored medical residents during their training periods, providing guidance on career development and professional growth opportunities.
- Served on academic committees, collaborating with colleagues to promote continuous improvement within the institution''s overall educational experience.
Director, Institute for Preventive Medicine
Department of Medicine
07.1998 - 06.2001
- Worked closely with organizational leadership and board of directors to guide operational strategy.
- Strengthened internal controls by reviewing existing policies and procedures, ensuring compliance with regulatory requirements.
- Facilitated cross-functional collaboration for improved decision-making processes within the organization.
- Formed strategic partnerships and connected with potential clients to drive business development.
Director, Inpatient Teaching Medicine Service
-BCM-Inpatient Manager Service/Hospitalist Service
07.1997 - 06.1999
- Enhanced team collaboration through regular communication, goal setting, and performance evaluations.
- Implemented innovative solutions to solve complex problems, resulting in increased productivity and streamlined operations.
- Managed daily operations while overseeing multiple locations to foster increased productivity.
- Formed strategic partnerships and connected with potential clients to drive business development.
- Optimized staff performance by designing comprehensive training programs tailored to individual needs.
Education
M.D. -
Meharry Medical College
Nashville, TN05.1991
Bachelor of Science in Chemistry -
Xavier University of Louisiana
New Orleans, LA05.1987
Skills
- Teamwork and Collaboration
- Problem-Solving
- Time Management
- Attention to Detail
- Flexible and Adaptable
- Dependable and Responsible
- Excellent Communication
- Critical Thinking
- Organization and Time Management
- Decision-Making
Certification
- Texas State Board of Medical Examiners, 1992
- American Board of Internal Medicine (ABIM), 1994
- American Board of Internal Medicine (ABIM) - Recertification, 2004
- American Board of Internal Medicine (ABIM) - Recertification, 2015
Timeline
Chair of Diversity, Equity and Inclusion Committee
Weill Cornell Medicine
01.2022 - Current
Assistant Professor of Clinical Medicine
Weill Cornell Medical College at Houston Methodist
10.2020 - Current
Assistant Professor of Clinical Medicine
Houston Methodist Academic Institute
10.2020 - Current
Division Head of Hospital Medicine
Houston Methodist Hospital
01.2019 - Current
Service Line Chief of Internal Medicine
Baylor St. Luke’s Medical Center
06.2017 - 12.2018
Member of the Medical Executive Committee
Baylor St. Luke’s Medical Center
01.2017 - 12.2018
Regional Medical Director
Larkin and Stroh Associates- LSA Hospitalist
11.2014 - 12.2018
Attending/ Staff Physician
Assistant Clinical Professor of Medicine
11.2010 - 12.2018
Co- Medical Director (Co-PGL)
Inpatient Consultants of Texas-Hospitalist
11.2010 - 10.2014
Staff Physician
Diagnostic Clinic of Houston
01.2008 - 10.2010
Faculty for the Center for Cardiovascular Disease Prevention
Baylor College of Medicine/The Methodist DeBakey Heart Center
07.2002 - 01.2008
Director, Institute for Preventive Medicine
Department of Medicine
07.1998 - 06.2001
Director, Inpatient Teaching Medicine Service
-BCM-Inpatient Manager Service/Hospitalist Service
07.1997 - 06.1999
Attending/Staff Physician
The Methodist Hospital
07.1996 - 10.2010
Medical Director of Cardiac Rehabilitation
The Methodist DeBakey Heart Center
07.1996 - 01.2008
Assistant Professor of Medicine
Section of General Internal Medicine
06.1996 - 06.2002
M.D. -
Meharry Medical College
Bachelor of Science in Chemistry -
Xavier University of Louisiana
Medical Education
Meharry Medical College, Nashville, Tennessee, Doctor of Medicine (MD), 1991, Honors Graduate, Alpha Omega Alpha
Post Graduate Training
- Internship, Baylor College of Medicine, St. Luke’s Episcopal Hospital, Internal Medicine, Houston, Texas, 07/91, 06/92
- Residency, Baylor Affiliated Programs, Baylor College of Medicine, Internal Medicine, Houston, Texas, 07/92, 06/94
- Chief Medical Resident, Baylor College of Medicine, Ben Taub General Hospital, Internal Medicine, Houston, Texas, 07/94, 06/95
- Fellowship, Ochsner Alton Medical Foundation, Ochsner Clinic, Preventive Cardiology, New Orleans, Louisiana, 07/95, 06/96
Academic And Administrative Appointments
- Division Head of Hospital Medicine, Weill Cornell Medical College, The Houston Methodist Hospital, Houston, TX, 01/19, Present
- Assistant Professor of Clinical Medicine, Weill Cornell Medical College at Houston Methodist, The Houston Methodist Hospital, Houston, TX, 10/20, Present
- Assistant Professor of Clinical Medicine, Houston Methodist Academic Institute, The Houston Methodist Hospital, Houston, TX, 10/20, Present
- Service Line Chief of Internal Medicine, Baylor St. Luke’s Medical Center, CHI St. Luke’s Health, Houston, TX, 06/17, 12/18
- Member of the Medical Executive Committee, Baylor St. Luke’s Medical Center, Houston, TX, 01/17, 12/18
- Assistant Clinical Professor of Medicine, Baylor College of Medicine, Houston, TX, 01/17, 12/18
- Regional Medical Director, Larkin and Stroh Associates- LSA Hospitalist, Houston, TX, 11/14, 12/18
- Co-Medical Director (Co-PGL), Inpatient Consultants of Texas-Hospitalist, St. Luke’s Episcopal Hospital, Houston, TX, 11/10, 10/14
- Staff Physician, Diagnostic Clinic of Houston, Houston, Texas, 01/08, 10/10
- Faculty for the Center for Cardiovascular Disease Prevention, Baylor College of Medicine, The Methodist DeBakey Heart Center, Houston, TX, 07/02, 01/08
- Assistant Professor of Medicine, Section of Lipid and Atherosclerosis, The Center for Cardiovascular Disease Prevention, Baylor College of Medicine, Houston, TX, 07/02, 01/08
- Director, Institute for Preventive Medicine, Department of Medicine, Baylor College of Medicine, The Methodist Hospital, Houston, TX, 07/98, 06/01
- Acting Director, Institute for Preventive Medicine, Section of General Internal Medicine, Baylor College of Medicine, Houston, TX, 01/98, 06/98
- Director, Inpatient Teaching Medicine Service, Section of General Medicine, Baylor College of Medicine, Houston, TX, 07/97, 06/99
- Medical Director of Cardiac Rehabilitation, The Methodist DeBakey Heart Center, The Methodist Hospital, Houston, TX, 07/96, 12/08
- Assistant Professor of Medicine, Section of General Internal Medicine, Baylor College of Medicine, Houston, TX, 06/96, 06/02
Hospital Appointments
- Chief of Internal Medicine, Baylor St. Luke’s Medical Center, CHI St. Luke’s Health, Houston, TX, 06/17, Present
- Attending/Staff Physician, Baylor College of Medicine, St. Luke’s Episcopal Hospital, Houston, Texas, 11/10, Present
- Attending/Staff Physician, The Methodist Hospital, Houston, Texas, 07/96, 10/10
- Attending/Staff Physician, Baylor College of Medicine, Ben Taub General Hospital, Houston, Texas, 07/96, 10/08
Organizations Honors Awards
- Award for "Best Doctors in America" - 2008
- Award for "Best Doctors in America" - 2007
- Advisory Board for the Texas Medical Foundation - 2006
- Award for "Best Doctors in America" - 2006
- Award for "Best Doctors in America" - 2005
- Member of the Association of Black Cardiologist, Inc. - 2004
- Award for the "Best Doctors in America" - 2004
- Advisory Board for the Texas Medical Foundation - 2003
- Award for the "Best Doctors in America" - 2003
- Advisory Board for the American Heart Association Houston Chapter - 2002
- Award for "Best Doctors in America" - 2002
- Advisory Board, Texas Medical Foundation - Task Force for Health Care Disparities in African Americans - 2002
- Advisory Board, National Minority Health Institute - 2001
- Award for Excellence in Teaching - Baylor College of Medicine - 1998
- Member, American Association of Cardiovascular and Pulmonary Rehabilitation - 1997
- Texas Medical Association - 1996
- Member, American College of Physicians - 1993
- Member, American Medical Association - 1992
- The J.T. Miller Academic Scholarship - Top Graduate Honor Award - The Meharry Medical College - 1991
- Member, ALPHA OMEGA ALPHA - National Medical Honor Society - 1990
- Recipient, Thomas J. Brooks, III Scholarship, MMC - 1990
- President, Junior Medical Class, MMC - 1989
- President, Metro Life Academic Scholarship - 1989
- President, Sophomore Medical Class, MMC - 1988
- Recipient, Volunteer State Medical Association Scholarship, Nashville, TN - 1988
- Recipient, Clareth Scholarship, Memphis, TN, MMC - 1988
- Dean’s Honor Society, Xavier University - 1983-1987
- Vice President, Senior Undergraduate Class - 1987
- Member, Alpha Epsilon Delta - Chemistry Honor Society - 1987
- Recipient, Louise Drexel Scholarship - 1984-1987
Selected Publications Chapters
- Neal RC, Ferdinand KC, Ycas J, Miller E. Relationship of ethnic Origin, Gender, and Age to Blood Creatinine Kinase Levels. American Journal of Medicine 2009; 122: 73-78.
- Neal RC, Jones P. Complimentary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination. Vascular Health and Risk Management 2006;2(1):31-38.
- Ferdinand KC, Clark LT, Watson KE, Neal RC, Brown CD, for the ARIES study group. Comparison of efficacy and safety of Rosuvastatin versus Atorvastatin in African American patients. American Journal of Cardiology 2006;97:224-235.
- Neal RC and Ballantyne CB. Cardiac Rehabilitation: Statins and the Rationale for Implementation of Lipid-Lowering Therapy. Ch-13, pp.141-156. Cardiac Rehabilitation. Willaim E. Kraus and Steven Keteyain.
Research
- Ryan C. Neal, M.D., Genzyme, A Phase 2 randomized, double-blind, placebo-controlled, parallel-group, multicenter, dose selection study of AD2/hypoxia inducible factor (HIF) 1Alpha/VP16 in patients with intermittent claudication, To determine the ability of AD2/hypoxia-inducible factor (HIF) to improve the walking ability of patients with PAD.
- Ryan C. Neal, M.D., KOS, The dose response of Niacin ER/Lovastatin on peak walking time (PWT) in patients with intermittent claudication-a matrix design, To determine the ability of combination Niacin/Lovastatin to improve the walking ability of patients with PAD
- Ryan C. Neal, M.D., Vasogen Incorporated, A multi-center, randomized, double-blind, parallel group, placebo-controlled study of efficacy and safety of immune modulation therapy in improving walking distance in patients with intermittent claudication secondary to peripheral arterial disease, To learn if Immune Modulation Therapy (IMT) will improve walking distance and to study the efficacy and safety of IMT in patients with moderate to severe peripheral arterial disease.
- Ryan C. Neal, MD, KOS Pharmaceuticals, Inc., The ICPOP (Intermittent Claudication Proof of Principle) Study: The effect of niacin er/lovastatin on peak walking time in patients with intermittent claudication, To evaluate the safety and efficacy of Niacin ER/Lovastatin in patients with Intermittent Claudication.
- Ryan C. Neal, M.D., Novartis Pharmaceuticals, A randomized, double-blind, multicenter, positive controlled parallel group study to evaluate the safety and efficacy of Lotrel (amlodipine/benazepril compared to Zestoretic (hydrochlorothiazide/lisinopril) in hypertensive patients., To demonstrate the effectiveness of Lotrel (amlodipine/benazepril) compared to Zestoretic (hydrochlorothiazide/lisinopril) administered daily in patients with WHO classified grades 2 and 3 uncomplicated diastolic essential hypertension (mean sitting diastolic blood pressures [MSDBP] > 100 mmHg and < 115 mmHg).
- Ryan C. Neal, M.D., Astra Zeneca Pharmaceutical, A 6-week, randomized, open-label, comparative study to evaluate the efficacy and safety of Rosuvastatin and Atorvastatin in the treatment of hypercholesterolemia in African American subjects., To see if Rosuvastatin is effective in treating high cholesterol over a long period of time in African Americans.
- Ryan C. Neal, M.D., Otsuka America Pharmaceutical, Inc., A randomized, double-blind, placebo-controlled, multi-center, parallel-arm study to assess the long-term effect of pletal (cilostazol) versus placebo administered orally to patients with intermittent claudication secondary to peripheral arterial disease, To compare the long-term effects of Pletal to placebo in patients with intermittent claudication secondary to peripheral arterial disease (PAD) with regard to all-cause mortality, and cardiovascular and peripheral arterial morbidity and mortality, and adverse event profile
- Ryan C. Neal, M.D., Pfizer, Inc., A pilot study of rapid titration of lipid lowering therapy by algorithm guided management versus usual care in the cardiac rehabilitation program to achieve NCEP (national cholesterol educational program) goals., To determine if algorithm guided management in cardiac rehabilitation can improve lipid levels.
- Ryan C. Neal, M.D., N.I.H./NHLBI, Improved effectiveness of cardiac rehabilitation, A three-year evaluation of cardiac rehabilitation and secondary prevention combined to establish a comprehensive risk reduction program to assess the effectiveness of cardiac rehabilitation on evidence based guidelines and needed compliance parameters.
- Ryan C. Neal, M.D., Pfizer, Inc. (Parke-Davis), A 4-year, population based, randomized, open-label study comparing the effect of aggressive lipid lowering with atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease at risk of adverse outcomes., The major goals of this project are to show in hypercholesterolemic patients with established CAD, at risk of ischemic complications, that aggressive lipid lowering with atorvastatin therapy will decrease the incidence of ischemic events and resource utilization compared to usual medical care.
- Ryan C. Neal, M.D., Merck & Company, Inc., A triple-blind, parallel study to investigate the effect of losartan versus atenolol on the reduction of morbidity and mortality in hypertensive patients with left ventricular hypertrophy (LIFE)., The major goal of this study is to determine the effect of Losartan versus Atenolol on the reduction of morbidity and mortality in hypertensive patients with left ventricle hypertrophy.
- Ryan C. Neal, M.D., Schering Plough Research Institute, Long-term, open-label, safety and tolerability study of SCH58235 in subjects with primary hypercholesterolemia., To evaluate the long term safety and tolerability of investigational drug SCH58235 (10mg), dosed daily for up to 24 months in lowering blood cholesterol.
- Ryan C. Neal, M.D., United Therapeutics Corporation, A multi-center, double-blind, randomized, parallel placebo-controlled study of the safety and efficacy of chronic oral beraprost sodium in patients with intermittent claudication (fontaine stage ii peripheral arterial occlusive disease)., The primary objective of this study is to evaluate the effect of Beraprost Sodium (BPS) on exercise capacity as assessed by a defined treadmill walk test in patients with intermittent claudication (Fontaine stage II peripheral arterial occlusive disease, of PAOD). Absolute claudication distance (ACD) will be the primary efficacy endpoint.
Personal Information
Date of Birth: 08/24/65
Medical Education
Meharry Medical College, Nashville, Tennessee, Doctor of Medicine (MD), 1991, Honors Graduate, Alpha Omega Alpha
Post Graduate Training
- Internship, Baylor College of Medicine, St. Luke’s Episcopal Hospital, Internal Medicine, Houston, Texas, 07/91, 06/92
- Residency, Baylor Affiliated Programs, Baylor College of Medicine, Internal Medicine, Houston, Texas, 07/92, 06/94
- Chief Medical Resident, Baylor College of Medicine, Ben Taub General Hospital, Internal Medicine, Houston, Texas, 07/94, 06/95
- Fellowship, Ochsner Alton Medical Foundation, Ochsner Clinic, Preventive Cardiology, New Orleans, Louisiana, 07/95, 06/96
Academic And Administrative Appointments
- Division Head of Hospital Medicine, Weill Cornell Medical College, The Houston Methodist Hospital, Houston, TX, 01/19, Present
- Assistant Professor of Clinical Medicine, Weill Cornell Medical College at Houston Methodist, The Houston Methodist Hospital, Houston, TX, 10/20, Present
- Assistant Professor of Clinical Medicine, Houston Methodist Academic Institute, The Houston Methodist Hospital, Houston, TX, 10/20, Present
- Service Line Chief of Internal Medicine, Baylor St. Luke’s Medical Center, CHI St. Luke’s Health, Houston, TX, 06/17, 12/18
- Member of the Medical Executive Committee, Baylor St. Luke’s Medical Center, Houston, TX, 01/17, 12/18
- Assistant Clinical Professor of Medicine, Baylor College of Medicine, Houston, TX, 01/17, 12/18
- Regional Medical Director, Larkin and Stroh Associates- LSA Hospitalist, Houston, TX, 11/14, 12/18
- Co-Medical Director (Co-PGL), Inpatient Consultants of Texas-Hospitalist, St. Luke’s Episcopal Hospital, Houston, TX, 11/10, 10/14
- Staff Physician, Diagnostic Clinic of Houston, Houston, Texas, 01/08, 10/10
- Faculty for the Center for Cardiovascular Disease Prevention, Baylor College of Medicine, The Methodist DeBakey Heart Center, Houston, TX, 07/02, 01/08
- Assistant Professor of Medicine, Section of Lipid and Atherosclerosis, The Center for Cardiovascular Disease Prevention, Baylor College of Medicine, Houston, TX, 07/02, 01/08
- Director, Institute for Preventive Medicine, Department of Medicine, Baylor College of Medicine, The Methodist Hospital, Houston, TX, 07/98, 06/01
- Acting Director, Institute for Preventive Medicine, Section of General Internal Medicine, Baylor College of Medicine, Houston, TX, 01/98, 06/98
- Director, Inpatient Teaching Medicine Service, Section of General Medicine, Baylor College of Medicine, Houston, TX, 07/97, 06/99
- Medical Director of Cardiac Rehabilitation, The Methodist DeBakey Heart Center, The Methodist Hospital, Houston, TX, 07/96, 12/08
- Assistant Professor of Medicine, Section of General Internal Medicine, Baylor College of Medicine, Houston, TX, 06/96, 06/02
Hospital Appointments
- Chief of Internal Medicine, Baylor St. Luke’s Medical Center, CHI St. Luke’s Health, Houston, TX, 06/17, Present
- Attending/Staff Physician, Baylor College of Medicine, St. Luke’s Episcopal Hospital, Houston, Texas, 11/10, Present
- Attending/Staff Physician, The Methodist Hospital, Houston, Texas, 07/96, 10/10
- Attending/Staff Physician, Baylor College of Medicine, Ben Taub General Hospital, Houston, Texas, 07/96, 10/08
Organizations Honors Awards
- Award for "Best Doctors in America" - 2008
- Award for "Best Doctors in America" - 2007
- Advisory Board for the Texas Medical Foundation - 2006
- Award for "Best Doctors in America" - 2006
- Award for "Best Doctors in America" - 2005
- Member of the Association of Black Cardiologist, Inc. - 2004
- Award for the "Best Doctors in America" - 2004
- Advisory Board for the Texas Medical Foundation - 2003
- Award for the "Best Doctors in America" - 2003
- Advisory Board for the American Heart Association Houston Chapter - 2002
- Award for "Best Doctors in America" - 2002
- Advisory Board, Texas Medical Foundation - Task Force for Health Care Disparities in African Americans - 2002
- Advisory Board, National Minority Health Institute - 2001
- Award for Excellence in Teaching - Baylor College of Medicine - 1998
- Member, American Association of Cardiovascular and Pulmonary Rehabilitation - 1997
- Texas Medical Association - 1996
- Member, American College of Physicians - 1993
- Member, American Medical Association - 1992
- The J.T. Miller Academic Scholarship - Top Graduate Honor Award - The Meharry Medical College - 1991
- Member, ALPHA OMEGA ALPHA - National Medical Honor Society - 1990
- Recipient, Thomas J. Brooks, III Scholarship, MMC - 1990
- President, Junior Medical Class, MMC - 1989
- President, Metro Life Academic Scholarship - 1989
- President, Sophomore Medical Class, MMC - 1988
- Recipient, Volunteer State Medical Association Scholarship, Nashville, TN - 1988
- Recipient, Clareth Scholarship, Memphis, TN, MMC - 1988
- Dean’s Honor Society, Xavier University - 1983-1987
- Vice President, Senior Undergraduate Class - 1987
- Member, Alpha Epsilon Delta - Chemistry Honor Society - 1987
- Recipient, Louise Drexel Scholarship - 1984-1987
Selected Publications Chapters
- Neal RC, Ferdinand KC, Ycas J, Miller E. Relationship of ethnic Origin, Gender, and Age to Blood Creatinine Kinase Levels. American Journal of Medicine 2009; 122: 73-78.
- Neal RC, Jones P. Complimentary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination. Vascular Health and Risk Management 2006;2(1):31-38.
- Ferdinand KC, Clark LT, Watson KE, Neal RC, Brown CD, for the ARIES study group. Comparison of efficacy and safety of Rosuvastatin versus Atorvastatin in African American patients. American Journal of Cardiology 2006;97:224-235.
- Neal RC and Ballantyne CB. Cardiac Rehabilitation: Statins and the Rationale for Implementation of Lipid-Lowering Therapy. Ch-13, pp.141-156. Cardiac Rehabilitation. Willaim E. Kraus and Steven Keteyain.
Research
- Ryan C. Neal, M.D., Genzyme, A Phase 2 randomized, double-blind, placebo-controlled, parallel-group, multicenter, dose selection study of AD2/hypoxia inducible factor (HIF) 1Alpha/VP16 in patients with intermittent claudication, To determine the ability of AD2/hypoxia-inducible factor (HIF) to improve the walking ability of patients with PAD.
- Ryan C. Neal, M.D., KOS, The dose response of Niacin ER/Lovastatin on peak walking time (PWT) in patients with intermittent claudication-a matrix design, To determine the ability of combination Niacin/Lovastatin to improve the walking ability of patients with PAD
- Ryan C. Neal, M.D., Vasogen Incorporated, A multi-center, randomized, double-blind, parallel group, placebo-controlled study of efficacy and safety of immune modulation therapy in improving walking distance in patients with intermittent claudication secondary to peripheral arterial disease, To learn if Immune Modulation Therapy (IMT) will improve walking distance and to study the efficacy and safety of IMT in patients with moderate to severe peripheral arterial disease.
- Ryan C. Neal, MD, KOS Pharmaceuticals, Inc., The ICPOP (Intermittent Claudication Proof of Principle) Study: The effect of niacin er/lovastatin on peak walking time in patients with intermittent claudication, To evaluate the safety and efficacy of Niacin ER/Lovastatin in patients with Intermittent Claudication.
- Ryan C. Neal, M.D., Novartis Pharmaceuticals, A randomized, double-blind, multicenter, positive controlled parallel group study to evaluate the safety and efficacy of Lotrel (amlodipine/benazepril compared to Zestoretic (hydrochlorothiazide/lisinopril) in hypertensive patients., To demonstrate the effectiveness of Lotrel (amlodipine/benazepril) compared to Zestoretic (hydrochlorothiazide/lisinopril) administered daily in patients with WHO classified grades 2 and 3 uncomplicated diastolic essential hypertension (mean sitting diastolic blood pressures [MSDBP] > 100 mmHg and < 115 mmHg).
- Ryan C. Neal, M.D., Astra Zeneca Pharmaceutical, A 6-week, randomized, open-label, comparative study to evaluate the efficacy and safety of Rosuvastatin and Atorvastatin in the treatment of hypercholesterolemia in African American subjects., To see if Rosuvastatin is effective in treating high cholesterol over a long period of time in African Americans.
- Ryan C. Neal, M.D., Otsuka America Pharmaceutical, Inc., A randomized, double-blind, placebo-controlled, multi-center, parallel-arm study to assess the long-term effect of pletal (cilostazol) versus placebo administered orally to patients with intermittent claudication secondary to peripheral arterial disease, To compare the long-term effects of Pletal to placebo in patients with intermittent claudication secondary to peripheral arterial disease (PAD) with regard to all-cause mortality, and cardiovascular and peripheral arterial morbidity and mortality, and adverse event profile
- Ryan C. Neal, M.D., Pfizer, Inc., A pilot study of rapid titration of lipid lowering therapy by algorithm guided management versus usual care in the cardiac rehabilitation program to achieve NCEP (national cholesterol educational program) goals., To determine if algorithm guided management in cardiac rehabilitation can improve lipid levels.
- Ryan C. Neal, M.D., N.I.H./NHLBI, Improved effectiveness of cardiac rehabilitation, A three-year evaluation of cardiac rehabilitation and secondary prevention combined to establish a comprehensive risk reduction program to assess the effectiveness of cardiac rehabilitation on evidence based guidelines and needed compliance parameters.
- Ryan C. Neal, M.D., Pfizer, Inc. (Parke-Davis), A 4-year, population based, randomized, open-label study comparing the effect of aggressive lipid lowering with atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease at risk of adverse outcomes., The major goals of this project are to show in hypercholesterolemic patients with established CAD, at risk of ischemic complications, that aggressive lipid lowering with atorvastatin therapy will decrease the incidence of ischemic events and resource utilization compared to usual medical care.
- Ryan C. Neal, M.D., Merck & Company, Inc., A triple-blind, parallel study to investigate the effect of losartan versus atenolol on the reduction of morbidity and mortality in hypertensive patients with left ventricular hypertrophy (LIFE)., The major goal of this study is to determine the effect of Losartan versus Atenolol on the reduction of morbidity and mortality in hypertensive patients with left ventricle hypertrophy.
- Ryan C. Neal, M.D., Schering Plough Research Institute, Long-term, open-label, safety and tolerability study of SCH58235 in subjects with primary hypercholesterolemia., To evaluate the long term safety and tolerability of investigational drug SCH58235 (10mg), dosed daily for up to 24 months in lowering blood cholesterol.
- Ryan C. Neal, M.D., United Therapeutics Corporation, A multi-center, double-blind, randomized, parallel placebo-controlled study of the safety and efficacy of chronic oral beraprost sodium in patients with intermittent claudication (fontaine stage ii peripheral arterial occlusive disease)., The primary objective of this study is to evaluate the effect of Beraprost Sodium (BPS) on exercise capacity as assessed by a defined treadmill walk test in patients with intermittent claudication (Fontaine stage II peripheral arterial occlusive disease, of PAOD). Absolute claudication distance (ACD) will be the primary efficacy endpoint.
Personal Information
Date of Birth: 08/24/65
Similar Profiles
LUZ FUENTESLUZ FUENTES
Phlebotomy Student at Houston Methodist Hospital – The Woodlands, TXPhlebotomy Student at Houston Methodist Hospital – The Woodlands, TX
Yenely CarpenterYenely Carpenter
Sterile Processing Technician at Houston Methodist HospitalSterile Processing Technician at Houston Methodist Hospital
Pamela Mattox BlackmonPamela Mattox Blackmon
Manager Case Management and Social Work Department at Houston Methodist HospitalManager Case Management and Social Work Department at Houston Methodist Hospital
NATALIA L. SAMUELSNATALIA L. SAMUELS
Acute Care Nurse Practitioner at Houston Methodist Hospital Texas Medical CenterAcute Care Nurse Practitioner at Houston Methodist Hospital Texas Medical Center
Leonela DuranLeonela Duran
Front of House Manager at Center HoustonFront of House Manager at Center Houston